ChrysCapital sells 2.9% in Mankind Pharma for Rs.2,470-Cr
ChrysCapital has divested a 2.9 % stake in New Delhi-headquartered pharmaceutical firm Mankind Pharma for INR 2,470 crore through open market transactions. Beige Ltd, an affiliate of Mauritius-based private equity firm ChrysCapital, offloaded more than 1.16 crore shares, amounting to a 2.9% stake in the company, in two tranches on the National Stock Exchange (NSE). The shares were sold in the price range of INR 2,120.31-2,124.71 apiece, taking the combined transaction value to INR 2,469.70 crore.In December 2023, ChrysCapital had sold a 4.47% stake in Mankind Pharma.Mankind Pharma develops, manufactures, and markets pharmaceutical formulations across various acute and chronic therapeutic areas and several consumer healthcare products.
Want to receive such news items in your inbox? Click Here to sign up for a trial.